Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug

NCT01630057 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Seizures

Interventions

DRUG: Adjunctive Zonisamide
DRUG: Replacement with Zonisamide

Sponsor

Eisai Inc.